MRM-MS | GenomeWeb

MRM-MS

The deal provides Sciex with the rights to commercialize immune-MRM technology developed by Amanda Paulovich's laboratory.

NEW YORK (GenomeWeb) – Integrated Diagnostics said this week that it has obtained $47.25 million in funding, $30.25 million from the closing of its Series B round and $17 million in non-dilutive debt financing from Life Sciences Alternative Funding.

NEW YORK (GenomeWeb News) – Applied Proteomics said today that it has closed a $28 million Series C financing round.

Researchers at the University of Victoria, Genome British Columbia Proteomics Centre have developed a multiplexed multiple-reaction monitoring mass spec assay capable of quantifying 142 proteins in undepleted and non-enriched human plasma in a single run.

NEW YORK (GenomeWeb News) – Agilent Technologies and Applied Proteomics today announced a collaboration to develop multiplex protein assays and workflow solutions for multiple reaction monitoring (MRM) using mass spectrometry.

Sera Prognostics said this week that it has exceeded enrollment of 4,000 subjects in its Proteomic Assessment of Preterm Risk clinical study supporting the validation of its proteomic test for predicting risk of preterm birth.

The National Cancer Institute last week announced a memorandum of understanding with Seoul National University Cancer Hospital under which SNUCH will test proteomic technologies, standards, workflows, and assays developed by NCI's Clinical Proteomic Tumor Analysis Consortium, CPT

You might say 2012 was the year that proteomics shed its Rodney Dangerfield routine and began to get some respect.

While targeted mass spec techniques like multiple-reaction monitoring continue to wrestle with issues of sample preparation, throughput, and sensitivity, recent publications and presentations suggest that the technology has gained a foothold in both industry and academia as a res

Caprion Proteomics aims next year to open a CLIA lab for protein biomarker-based diagnostics, several of which will likely be run on a mass spec platform, a company official told ProteoMonitor this week.

Pages

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.